Rapidly progressive glomerulonephritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{AEL}}  
{{CMG}} {{AE}} {{AEL}}  


==Overview==  
==Overview==
The incidence of RPGN is 1 per 1 million individuals per year and the incidence is affected by race and age.
 
==Epidemiology and demographics==  
==Epidemiology and demographics==  
===Incidence===
===Incidence===
* The [[incidence]] of rapidly progressive glomerulonephritis  is around 1 per million individuals per year.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105  }}</ref> <ref name="pmid11007827">{{cite journal| author=Hedger N, Stevens J, Drey N, Walker S, Roderick P| title=Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. | journal=Nephrol Dial Transplant | year= 2000 | volume= 15 | issue= 10 | pages= 1593-9 | pmid=11007827 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11007827  }} </ref>
* The [[incidence]] of rapidly progressive glomerulonephritis  is around 1 per million individuals per year.<ref name="pmid21769105">{{cite journal| author=Cui Z, Zhao MH| title=Advances in human antiglomerular basement membrane disease. | journal=Nat Rev Nephrol | year= 2011 | volume= 7 | issue= 12 | pages= 697-705 | pmid=21769105 | doi=10.1038/nrneph.2011.89 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21769105  }}</ref> <ref name="pmid11007827">{{cite journal| author=Hedger N, Stevens J, Drey N, Walker S, Roderick P| title=Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. | journal=Nephrol Dial Transplant | year= 2000 | volume= 15 | issue= 10 | pages= 1593-9 | pmid=11007827 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11007827  }} </ref>


=== Prevalance ===
* The prevalence of rapidly progressive glomerulonephritis increases with age.
* The prevalence of rapidly progressive glomerulonephritis increases with age.


Line 15: Line 18:
===Gender===
===Gender===
* Men and women are affected equally by rapidly progressive glomerulonephritis.
* Men and women are affected equally by rapidly progressive glomerulonephritis.
=== Age ===
* It is more common in old individuals.


==References==
==References==

Revision as of 16:18, 24 July 2018

Rapidly progressive glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rapidly progressive glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray Findings

CT-scan Findings

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rapidly progressive glomerulonephritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rapidly progressive glomerulonephritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rapidly progressive glomerulonephritis epidemiology and demographics

CDC on Rapidly progressive glomerulonephritis epidemiology and demographics

Rapidly progressive glomerulonephritis epidemiology and demographics in the news

Blogs on Rapidly progressive glomerulonephritis epidemiology and demographics

Directions to Hospitals Treating Rapidly progressive glomerulonephritis

Risk calculators and risk factors for Rapidly progressive glomerulonephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]

Overview

The incidence of RPGN is 1 per 1 million individuals per year and the incidence is affected by race and age.

Epidemiology and demographics

Incidence

  • The incidence of rapidly progressive glomerulonephritis is around 1 per million individuals per year.[1] [2]

Prevalance

  • The prevalence of rapidly progressive glomerulonephritis increases with age.

Race

  • Rapidly progressive glomerulonephritis is more prevalent in the white race more than the black race.

Gender

  • Men and women are affected equally by rapidly progressive glomerulonephritis.

Age

  • It is more common in old individuals.

References

  1. Cui Z, Zhao MH (2011). "Advances in human antiglomerular basement membrane disease". Nat Rev Nephrol. 7 (12): 697–705. doi:10.1038/nrneph.2011.89. PMID 21769105.
  2. Hedger N, Stevens J, Drey N, Walker S, Roderick P (2000). "Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study". Nephrol Dial Transplant. 15 (10): 1593–9. PMID 11007827.

Template:WH Template:WS